![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
FDA Approves First Medication for Obstructive Sleep Apnea
Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be used in...
FDA approves weight loss drug Zepbound for sleep apnea - NBC News
Dec 20, 2024 · The Food and Drug Administration expanded the approval of weight loss drug Zepbound to treat obstructive sleep apnea in adults with obesity, the drugmaker Eli Lilly said …
FDA Approves Zepbound for Obstructive Sleep Apnea - WebMD
Dec 23, 2024 · Results showed that Zepbound significantly reduced breathing interruptions (apnea and hypopnea) during sleep compared to the placebo. More patients treated with …
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
Dec 20, 2024 · For people with obstructive sleep apnea, Zepbound should be used with a reduced-calorie diet and increased physical activity, drugmaker Eli Lilly said. The US Food …
GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea
Dec 23, 2024 · The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug …
FDA approves weight loss drug Zepbound to treat sleep apnea : …
Dec 21, 2024 · The Food and Drug Administration on Friday authorized the use of Zepbound, made by Eli Lilly & Co., for adults with obesity and moderate to severe obstructive sleep apnea …
GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea - U.S. News …
MONDAY, Dec. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea …
Zepbound approved for sleep apnea - USA TODAY
Dec 20, 2024 · The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity.
FDA approves Zepbound® (tirzepatide) as the first and only …
Dec 20, 2024 · Zepbound ® (tirzepatide) injection is FDA-approved to treat adults with moderate-to-severe obstructive sleep apnea and obesity. It is also approved in combination with a …
First Sleep Apnea Drug, Zepbound (Tirzepatide), Gets FDA Okay
Dec 27, 2024 · Zepbound Effective in Reducing the Severity of OSA. The approval of Zepbound for obstructive sleep apnea treatment is based on the results of two major studies from the …
- Some results have been removed